Pharmaceuticals
Florida to become first state to end all vaccine mandates, including in schools
Ruth Jones, immunization nurse, holds a Pfizer-BioNTech COVID-19 vaccine (brand name: Comirnaty) at Borinquen Health Care Center in Miami, Florida, on May 29, 2025. Joe Raedle | Getty Images Florida plans to end all state vaccine mandates, including for children to attend schools, state Surgeon General Joseph Ladapo, a prominent immunization critic, announced Wednesday. The […]
Read More
Amgen to invest $600 million in new research and development facility in California
Building rendering of a new, state-of-the-art science and innovation center at Amgen’s global headquarters in Thousand Oaks, California. Courtesy: Amgen Amgen on Tuesday said it will spend more than $600 million to build a new research and development facility at its headquarters in Thousand Oaks, California, the latest in a string of new U.S. investments […]
Read More
Trump tells drugmakers to ‘justify the success’ of Covid meds after FDA limits vaccine approval
U.S. President Donald Trump in the Cabinet Room of the White House on Aug. 26, 2025 in Washington, D.C. Chip Somodevilla | Getty Images President Donald Trump on Monday called on pharmaceutical companies to “justify the success” of their Covid drugs days after the Food and Drug Administration set new limits on who can receive […]
Read More
CDC asks all staff to return to office Sept. 15, five weeks after shooting at headquarters
A sign for the CDC sits outside of their facility at the Centers for Disease Control and Prevention Roybal campus in Atlanta, Georgia, U.S., May 30, 2025. Megan Varner | Reuters The Centers for Disease Control and Prevention told staff it expects them to return to offices by Sept. 15, roughly five weeks after a […]
Read More
The vaccine and public health debate at the center of CDC upheaval, explained
The exterior of the Center for Disease Control and Prevention (CDC) main campus in Atlanta, Georgia, U.S., Aug. 27, 2025. Alyssa Pointer | Reuters The Centers for Disease Control and Prevention is facing a leadership upheaval — and at the center of the shakeup is concern about the agency’s approach to vaccines and U.S. public […]
Read More
CDC Director Susan Monarez ousted, four other leaders quit health agency
Susan Monarez, President Donald Trump’s nominee to be the Director of the Centers for Disease Control and Prevention (CDC), testifies during her confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions in the Dirksen Senate Office Building on June 25, 2025 in Washington, DC. Kayla Bartkowski | Getty Images Centers for Disease […]
Read More
MAHA loves dietary supplements. But that hasn’t led to gains in Washington — yet.
An avid consumer of dietary supplements, Health and Human Services Secretary Robert F. Kennedy Jr. has surrounded himself in part with senior staff members, advisers and health influencers who have promoted everything from weight loss pills to capsules of desiccated organ meat. But that hasn’t led to gains in Washington for the multibillion-dollar industry — yet. […]
Read More
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Eli Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023. Mike Blake | Reuters Eli Lilly on Tuesday said its daily weight loss pill helped patients with obesity and Type 2 diabetes shed weight in a late-stage trial, meeting the study’s main goal and clearing the way for the company to […]
Read More
A world on weight loss drugs: How GLP-1s are reshaping the economy
Eternalcreative | Istock | Getty Images Miracle drugs, obesity treatments and skinny jabs. Call them what you will, few drugs have had a more transformative effect on Wall Street and waistlines over recent decades than GLP-1s. Familiarly known under the brand names Wegovy and Zepbound, Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medication used to […]
Read More
Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly‘s stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street. In a key late-stage trial, […]
Read More